The BioProcess Institute (BPI) was founded by James Dean Vogel P.E. in 2007.
Since then, Jim has been leading a team of professionals whose collective expertise and resources in the areas of industry, regulation, and science helps companies navigate the complex world of bioprocessing so the industry can make better drugs.
Jim has been appointed to leadership positions at highly respected industry organizations, such as the ASME, the BPSA, and ISPE. This prominence allows unprecedented access to industry knowledge, thought leaders, and emerging trends in the field as they are happening.
BPI’s mission is to effectively address the high priority needs of growing and evolving biologics manufacturers and end users through consulting, testing, and training. BPI’s broad client list ranges from Fortune 500 companies to start-up manufacturers and their suppliers in the biopharmaceutical, pharmaceutical, food, and cosmetics industries.
The BioProcess Institute is committed to remaining a world leader in bioprocess science by providing clients with reality-based solutions which are deeply rooted in good science and practice.